Wexford Capital’s Eli Lilly LLY Stock Holding History

Wexford Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Buy	+499	New	+$510K	0.08%	97
2025 Q4	–	Sell	-388	Closed	-$296K	–	459
2025 Q3	$296K	Buy	+388	New	+$289K	0.04%	137
2024 Q4	–	Sell	-1,871	Closed	-$1.66M	–	230
2024 Q3	$1.66M	Buy	+1,871	New	+$1.68M	0.4%	49
2024 Q1	–	Sell	-5,335	Closed	-$3.11M	–	259
2023 Q4	$3.11M	Sell	5,335 -141	-3%	-$82.3K	0.67%	45
2023 Q3	$2.94M	Buy	+5,476	New	+$2.82M	0.65%	36
2022 Q4	–	Sell	-813	Closed	-$263K	–	162
2022 Q3	$263K	Buy	813 +2	+0.2%	+$634	0.08%	107
2022 Q2	$263K	Buy	811 +2	+0.2%	+$600	0.02%	143
2022 Q1	$232K	Buy	+809	New	+$208K	0.01%	137
2013 Q3	–	Sell	-21,822	Closed	-$1.07M	–	238
2013 Q2	$1.07M	Buy	+21,822	New	+$1.19M	0.09%	109

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wexford Capital's LLY Position: Q2 2026 in Review

Wexford Capital opened a new position in Eli Lilly (LLY) in Q2 2026: 499 shares worth $599K. The stake represents 0.08% of the portfolio and ranks #97 among its holdings. This is a return to the name: Wexford Capital previously reported a position in LLY as recently as Q3 2025.

Wexford Capital first reported a position in LLY in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.11M in Q4 2023. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Wexford Capital held 499 shares of Eli Lilly worth $599K as of Q2 2026.
Eli Lilly was a new Wexford Capital position in Q2 2026.
Eli Lilly made up 0.08% of Wexford Capital's portfolio in Q2 2026, its #97 holding.
Wexford Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 9 quarters since.
Wexford Capital's Eli Lilly position peaked at $3.11M in Q4 2023.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wexford Capital's 13F filing for Q2 2026, filed 14 Aug 2026.